home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Cannara Biotech Inc (OP:LOVFF)

1.330 UNCHANGED

Streaming Delayed Price Updated: 3:31 PM EST, Jan 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cannara Biotech Inc

< Previous 1 2 Next >

The 7 Most Undervalued Cannabis Stocks to Buy in December ↗

December 14, 2023

These seven cannabis stocks are either undervalued based on traditional metrics, or are undervalued relative to future potential.

Via InvestorPlace

Topics Cannabis

This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices ↗

December 07, 2023

Nicholas Sosiak, CFO of Cannara Biotech (TSXV: LOVE.V) (OTCQB: LOVFF) (FRA: 8CB) was recently interviewed by Benzinga.

Via Benzinga

Topics Cannabis

Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023 ↗

August 21, 2023

Via Benzinga

Topics Cannabis

7 Smoking-Hot 420 Stocks to Buy in 2023 ↗

August 17, 2023

A blaze of renewed bullishness may be just around the corner for these seven cannabis plays, making them top 420 stocks to buy.

Via InvestorPlace

Topics Cannabis

Cannabis Stock Movers For August 10, 2023 ↗

August 10, 2023

Via Benzinga

Topics Cannabis

Cannara Biotech Q3 FY23 Net Revenue Grows 57% YoY, What About Adjusted EBITDA? ↗

July 27, 2023

Cannara Biotech Inc.

Via Benzinga

Cannabis Stock Gainers And Losers From August 4, 2023 ↗

August 04, 2023

Via Benzinga

Cannabis Stock Gainers And Losers From July 25, 2023 ↗

July 25, 2023

Via Benzinga

Marijuana Stock Movers For August 1, 2023 ↗

August 01, 2023

Via Benzinga

Cannara Biotech Secures An Additional $10M In Non-Dilutive Capital With Its Lead Credit Provider, BMO Commercial Banking ↗

May 04, 2023

Cannara Biotech Inc.

Via Benzinga

Cannara Biotech Q2 FY23 Revenue Grows 76% YoY To $9.6M, Here Are The Details ↗

April 24, 2023

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) released its fiscal second quarter 2023 financial results, revealing net revenue of CA$13 million ($9.6 million), a 76% increase, compared to...

Via Benzinga

Cannabis Stock Movers For July 27, 2023 ↗

July 27, 2023

Via Benzinga

Olymbec Investments Increases Its Ownership In Cannara Biotech ↗

February 10, 2023

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) held its annual shareholder meeting on January 25, 2023.

Via Benzinga

Cannara Biotech Q1 Revenue Grows 57% YoY To $7.7M, What About Adjusted EBITDA? ↗

January 23, 2023

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) released its fiscal first quarter 2023 financial results for the three-month period ended November 30, 2022, revealing revenue of CA$10.3...

Via Benzinga

Cannara Biotech Q4 Revenue Grows 84% YoY To $8.9M ↗

November 28, 2022

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) released its fiscal fourth quarter and fiscal year 2022 financial results for the three-month and full year periods ended August 31, 2022,...

Via Benzinga

Cannara Biotech Enters Into The British Columbia Cannabis Market And Launches New Products ↗

September 20, 2022

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB), a Quebec-based, vertically integrated producer of cannabis and derivative product offerings, entered into the British Columbia (BC) market.

Via Benzinga

Cannara Biotech Signs An Exclusive Brand Partnership With Exotic Genetix In Canada ↗

August 03, 2022

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) entered into an exclusive brand partnership with Exotic Genetix Ltd.

Via Benzinga

Cannara Biotech Revenue Grows 41% YoY, Here Are The Details ↗

July 27, 2022

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) fiscal Q3 2022 revenue was $10.1 million, a 36% increase from the previous quarter and a 41% increase compared to Q3 2021.

Via Benzinga

Cannara Biotech Closes $50 Million Credit Facility Led By BMO Commercial Banking ↗

June 02, 2022

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) has closed on a $50M credit facility led by BMO Commercial Banking.

Via Benzinga

Cannara Biotech Revenues Grew 229% To $7.4M In Q2 2022 YoY ↗

April 27, 2022

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) released its fiscal second quarter 2022 financial and operating results for the three and six-month periods ended February 28, 2022.

Via Benzinga

The Week In Cannabis: Isiah Thomas, Tilray, The DEA, Ohio, Mexico And More ↗

December 10, 2021

Below is a recap of the main news related to the cannabis industry and markets for the week of December 6, 2021.

Via Benzinga

Topics Cannabis

Cannara Biotech Shares Surge On 983% QoQ Revenue Growth, Positive Adjusted EBITDA ↗

December 09, 2021

Vertically integrated cannabis company Cannara Biotech Inc. (TSXV:

Via Benzinga

Topics Cannabis

Tilray Best Performer Among Canadian Cannabis LPs, Stocks Plunge Nearly 10% In July ↗

August 02, 2021

Canadian cannabis stocks took a beating In July, with the Canadian Cannabis LP Index posting a 9.8% loss while continuing the decl...

Via Benzinga

Topics Cannabis

Cannara Biotech Cannabis Co. Slightly Beats Estimates, Posts $7.2M In Q3 2021 Revenue ↗

July 29, 2021

Vertically integrated cannabis company Cannara Biotech Inc. (TSXV:

Via Benzinga

Topics Cannabis

The Week In Cannabis: Justice Clarence Thomas, Mexico's Decriminalization, Apple's Policy Changes, Tilray And More ↗

July 02, 2021

Below is a recap of the main news related to the cannabis industry and markets for the week of June 28, 2021. Justice Thomas&nbs...

Via Benzinga

Topics Cannabis

Cannara Biotech Cannabis Co. Expects To Post $7.1M In Q3 Revenue After Successful Market Launch In Quebec ↗

June 28, 2021

Cannara Biotech Inc. (TSXV:LOVE) (OTCQB:

Via Benzinga

Topics Cannabis

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com